Get started
Author

Peter Madsen

Observed names: P H Madsen, P Madsen, P. H. MADSEN, P. H. Madsen, P. L. Madsen, P. MADSEN, P. Madsen, P.H MADSEN, P.H. Madsen, PETER MADSEN
Observed institutions: University of Copenhagen, Pfizer (United States), Novo Nordisk (Denmark), Aarhus University, Roskilde Sygehus, Aalborg University Hospital, Aarhus Municipality, Odense University Hospital, Aarhus University Hospital, Regionshospitalet Viborg
ORCID: 0000-0003-0398-7309
Observed ORCID: 0000-0003-0398-7309
OpenAlex ID: A5104635952
Bioavailability of marine n-3 fatty acid formulations
2010 · J. Dyerberg, P. Madsen, et al. · Prostaglandins Leukotrienes and Essential Fatty Acids · 257
Small-molecule agonists for the glucagon-like peptide 1 receptor
2007 · Lotte Bjerre Knudsen, Dan Kiel, et al. · Proceedings of the National Academy of Sciences · 231
Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing
2021 · Erica Nishimura, Lone Pridal, et al. · BMJ Open Diabetes Research & Care · 150
PDF
Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans
2021 · Thomas B. Kjeldsen, František Hubálek, et al. · Journal of Medicinal Chemistry · 133
Dose-Response Studies on the Effect of n-3 Polyunsaturated Fatty Acids on Lipids and Haemostasis
1990 · E Berg Schmidt, K Varming, et al. · Thrombosis and Haemostasis · 115
Dietary Supplementation with co‐3‐Polyunsaturated Fatty Acids Decreases Mononuclear Cell Proliferation and Interleukin‐1β Content but not Monokine Secretion in Healthy and Insulin‐Dependent Diabetic Individuals
1991 · J. MØLVIG, F. POCIOT, et al. · Scandinavian Journal of Immunology · 112
Discovery and Structure−Activity Relationship of the First Non-Peptide Competitive Human Glucagon Receptor Antagonists
1998 · Peter Madsen, Lotte B. Knudsen, et al. · Journal of Medicinal Chemistry · 92
Optimization of Alkylidene Hydrazide Based Human Glucagon Receptor Antagonists. Discovery of the Highly Potent and Orally Available 3-Cyano-4-hydroxybenzoic Acid [1-(2,3,5,6-Tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide
2002 · Peter Madsen, Anthony Ling, et al. · Journal of Medicinal Chemistry · 87
Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review
2016 · S. L. Rasmussen, H. B. Krarup, et al. · Colorectal Disease · 79
Changes in Glucose and Fat Metabolism in Response to the Administration of a Hepato-Preferential Insulin Analog
2014 · Dale S. Edgerton, Mary C. Moore, et al. · Diabetes · 70
Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor
2007 · Min Teng, Michael D. Johnson, et al. · Bioorganic & Medicinal Chemistry Letters · 65
Molecular engineering of safe and efficacious oral basal insulin
2020 · Frantisek Hubálek, Hanne H. F. Refsgaard, et al. · Nature Communications · 61
PDF
Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery
2019 · Dale S. Edgerton, Melanie Scott, et al. · JCI Insight · 59
PDF
Rubeosis of the iris and haemorrhagic glaucoma in patients with proliferative diabetic retinopathy.
1971 · P H Madsen · British Journal of Ophthalmology · 58
PDF
A quantitative HCV-PCR test for routine diagnostics
1998 · H B Krarup, A M Drewes, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 54
Novel Glucagon Receptor Antagonists with Improved Selectivity over the Glucose-Dependent Insulinotropic Polypeptide Receptor
2008 · János T. Kodra, Anker Steen Jørgensen, et al. · Journal of Medicinal Chemistry · 53
New β-Alanine Derivatives Are Orally Available Glucagon Receptor Antagonists
2007 · Jesper Lau, Carsten Behrens, et al. · Journal of Medicinal Chemistry · 53
Long-term supplementation with n-3 fatty acids, I: effect on blood lipids, haemostasis and blood pressure
1992 · E. B. Schmidt, H.-H. Lervang, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 52
Haemorrhagic glaucoma. Comparative study in diabetic and nondiabetic patients.
1971 · P H Madsen · British Journal of Ophthalmology · 52
PDF
Commemorating insulin's centennial: engineering insulin pharmacology towards physiology
2021 · Peter Kurtzhals, Erica Nishimura, et al. · Trends in Pharmacological Sciences · 50
PDF
Types of Exudates in Diabetic Retinopathy
1963 · V. Esmann, K. Lundbæk, et al. · Acta Medica Scandinavica · 47
Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320
2020 · Thomas B. Kjeldsen, František Hubálek, et al. · Journal of Medicinal Chemistry · 42
Human glucagon receptor antagonists based on alkylidene hydrazides
2002 · Anthony Ling, Michael Plewe, et al. · Bioorganic & Medicinal Chemistry Letters · 40
Glucose-6-phosphatase inhibitors for the treatment of Type 2 diabetes
2001 · Niels Westergaard, Peter Madsen · Expert Opinion on Therapeutic Patents · 36
Human Glucagon Receptor Antagonists with Thiazole Cores. A Novel Series with Superior Pharmacokinetic Properties
2009 · Peter Madsen, János T. Kodra, et al. · Journal of Medicinal Chemistry · 34
Works count: 78
Citation count: 2,461
H-index: 26
I10-index: 41
Year
Topic
Type